You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Making the Case for an Opioid Action Plan: The Role of Naloxone

  • Authors: Steven Stanos, DO; Kathleen Hanley, MD; Kevin L. Zacharoff, MD
  • CME / ABIM MOC / CE Released: 3/17/2021; Reviewed and Renewed: 3/17/2022
  • Valid for credit through: 3/17/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    Nurses - 0.50 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology)

    Pharmacists - 0.50 Knowledge-based ACPE (0.050 CEUs)

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for neurologists, anesthesiologists, and primary care physicians.

The goal of this activity is to inform clinicians about the prophylactic prescription of naloxone for patients who are appropriately prescribed an opioid analgesic.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding
    • The factors associated with an increased risk of overdose in patients receiving an appropriate prescription for an opioid analgesic
    • Guidance for the coprescription of naloxone with an opioid analgesic for the management of pain
  • Have greater competence related to
    • The identification of patients who are candidates for the prophylactic use of naloxone


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Moderator

  • Steven Stanos, DO

    Pain Medicine Specialist
    Swedish Health System
    Swedish Pain Services
    Seattle, Washington

    Disclosures

    Disclosure: Steven Stanos, DO, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Emergent BioSolutions; Hisamitsu; Lilly; Pfizer; Vertex

Panelists

  • Kathleen Hanley, MD

    Associate Professor
    Department of Medicine
    NYU Grossman School of Medicine
    New York, New York

    Disclosures

    Disclosure: Kathleen Hanley, MD, has disclosed no relevant financial relationships.

  • Kevin L. Zacharoff, MD

    Faculty and Clinical Instructor
    Course Director of Pain and Addiction
    Department of Family, Population, and Preventive Medicine
    Renaissance School of Medicine at Stony Brook University
    Stony Brook, New York

    Disclosures

    Disclosure: Kevin L. Zacharoff, MD, has disclosed no relevant financial relationships.

Editors

  • Kathy Merlo

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Kathy Merlo has disclosed no relevant financial relationships.

  • Andrew D. Bowser, ELS, CHCP

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Disclosure: Andrew D. Bowser, ELS, CHCP has disclosed the following relevant financial relationships:
    Spouse served as an advisor or consultant for CSL Behring and Pharming
    Spouse served as a speaker for Shire/Takeda

CME, CE Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements


In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape, LLC designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number JA0007105-0000-21-257-H08-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Making the Case for an Opioid Action Plan: The Role of Naloxone

Authors: Steven Stanos, DO; Kathleen Hanley, MD; Kevin L. Zacharoff, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 3/17/2021; Reviewed and Renewed: 3/17/2022

Valid for credit through: 3/17/2023

processing....

Educational Impact Challenge

 
 
 
 

The goal of this activity is to inform clinicians about the prophylactic prescription of naloxone for patients who are appropriately prescribed an opioid analgesic.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.